STXSStereotaxis, Inc.Healthcare · Medical - Equipment & Servicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $1.32 · now $1.32 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, STXS has typically landed between $0.98 and $1.67 — a range of −25.4% to +26.6% from the issuance price $1.32.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,000 overlapping 1 month windows · 2006-09-262026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($1.32) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where STXS has typically landed a month from the 2026-09-16 close of $1.32 — the range is history, not a prediction.

$0.9848worst · -25.4%$1.67best · +26.6%
  • now $1.32 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $1.31 (-1.0%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $1.17$1.45
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $0.9848$1.67
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,000 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2011-07-22−73.4%−73.4%+0.0%
2011-07-27−72.2%−72.2%+0.0%
2011-07-21−72.1%−72.1%+2.0%
3 best
2013-07-02+604.1%−0.8%+604.1%
2013-07-03+600.0%−7.6%+600.0%
2013-07-05+524.4%−3.9%+627.6%

5,000 overlapping windows · 2006-09-262026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
40%
−3.5%
n=20
Feb
60%
+10.9%
n=20
Mar
25%
−5.1%
n=20
Apr
40%
−2.9%
n=20
May
45%
−1.1%
n=20
Jun
40%
−3.6%
n=20
Jul
55%
+14.0%
n=20
Aug
45%
−6.4%
n=20
Sep
45%
+0.7%
n=20
Oct
45%
−0.3%
n=20
Nov
45%
+1.0%
n=20
Dec
55%
+3.0%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$4$12025-11-17: 1 insider purchase, $22K — Isaac Paul J2025-11-14: 1 insider purchase, $45K — Isaac Paul J2025-11: 2 open-market purchases, $67K↑ buys↓ salesdirector Isaac Paul J — Purchase on 2025-11-17, filed 1 day after the tradedirector Isaac Paul J — Purchase on 2025-11-14, filed 4 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2025-11-17Isaac Paul JdirectorPurchase10,000 @ $2.18$22K+11.5% of holding+8.6%−24.7%97,299Form 4 · filed 1 day after the trade
2025-11-14Isaac Paul JdirectorPurchase20,000 @ $2.24$45K+0.7% of holding+6.2%−31.9%2,786,557Form 4 · filed 4 days after the trade
2025-03-10Isaac Paul JdirectorPurchase38,000 @ $1.81$69K+77.1% of holding+1.6%+46.6%87,299Form 4 · filed 1 day after the trade
2025-03-07Isaac Paul JdirectorPurchase1,489 @ $1.79$3K+0.1% of holding+1.5%+40.7%2,766,557Form 4 · filed 3 days after the trade
2025-03-06Isaac Paul JdirectorPurchase23,299 @ $1.81$42K+90.4% of holding+3.2%+46.5%49,066Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

26 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-07-01Benfer DaviddirectorAward / grant43,103558,975Form 4
2026-07-01Curet MyriamdirectorAward / grant43,103435,161Form 4
2026-07-01Fischel NathandirectorAward / grant43,103720,775Form 4
2026-07-01Levin Ross BdirectorAward / grant43,103621,248Form 4
2026-07-01Menawat Arun SwarupdirectorAward / grant43,1031,035,560Form 4
2026-07-01SHAMIR NACHUMdirectorAward / grant43,103179,327Form 4
2026-04-11Peery Kimberly R.officerAward / grant40,000340,750Form 4
2026-01-02Fischel NathandirectorAward / grant46,948677,672Form 4
2026-01-02SHAMIR NACHUMdirectorAward / grant46,948136,224Form 4
2026-01-02Curet MyriamdirectorAward / grant46,948392,058Form 4
2026-01-02Menawat Arun SwarupdirectorAward / grant46,948992,457Form 4
2026-01-02Benfer DaviddirectorAward / grant46,948515,872Form 4
2026-01-02Levin Ross BdirectorAward / grant46,948578,145Form 4
2025-07-01Curet MyriamdirectorAward / grant43,668345,110Form 4
2025-07-01Benfer DaviddirectorAward / grant43,668468,924Form 4
2025-07-01Levin Ross BdirectorAward / grant43,668531,197Form 4
2025-07-01Fischel NathandirectorAward / grant43,668630,724Form 4
2025-07-01SHAMIR NACHUMdirectorAward / grant43,66889,276Form 4
2025-07-01Menawat Arun SwarupdirectorAward / grant43,668945,509Form 4
2025-04-08Peery Kimberly R.officerAward / grant50,000300,750Form 4
2025-01-02SHAMIR NACHUMdirectorAward / grant45,60845,608Form 4
2025-01-02Curet MyriamdirectorAward / grant56,497301,442Form 4
2025-01-02Fischel NathandirectorAward / grant56,497587,056Form 4
2025-01-02Benfer DaviddirectorAward / grant56,497425,256Form 4
2025-01-02Levin Ross BdirectorAward / grant56,497487,529Form 4
2025-01-02Menawat Arun SwarupdirectorAward / grant56,497901,841Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.